PAL1 THE IMPACT OF THE RX-TO-OTC SWITCH OF LORATADINE AND CHANGES IN PRESCRIPTION DRUG BENEFITS ON UTILIZATION AND COST OF THERAPY
May 1, 2005, 00:00
10.1016/S1098-3015(10)62893-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)62893-8/fulltext
Title :
PAL1 THE IMPACT OF THE RX-TO-OTC SWITCH OF LORATADINE AND CHANGES IN PRESCRIPTION DRUG BENEFITS ON UTILIZATION AND COST OF THERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62893-8&doi=10.1016/S1098-3015(10)62893-8
First page :
Section Title :
Open access? :
No
Section Order :
331